[TABLE OF CONTENTS]

1 INTRODUCTION OF GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES

4 GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE MODEL
4.4 VALUE CHAIN ANALYSIS

5 GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET, BY OFFERING
5.1 OVERVIEW
5.2 SOFTWARE
5.3 SERVICES

6 GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET, BY TECHNOLOGY
6.1 OVERVIEW
6.2 MACHINE LEARNING
6.2.1 DEEP LEARNING
6.2.2 SUPERVISED LEARNING
6.2.3 REINFORCEMENT LEARNING
6.2.4 UNSUPERVISED LEARNING
6.2.5 OTHER MACHINE LEARNING TECHNOLOGIES
6.3 COMPUTER VISION

7 GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET, BY FUNCTIONALITY
7.1 OVERVIEW
7.2 GENOME SEQUENCING
7.3 GENE EDITING
7.4 CLINICAL WORKFLOWS
7.5 PREDICTIVE GENETIC TESTING & PREVENTIVE MEDICINE 

8 GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET, BY APPLICATION
8.1 OVERVIEW
8.2 AGRICULTURE & ANIMAL RESEARCH
8.3 DIAGNOSTICS
8.4 PRECISION MEDICINE
8.5 DRUG DISCOVERY & DEVELOPMENT
8.6 OTHER APPLICATIONS

9 GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET, BY END-USER
9.1 OVERVIEW
9.2 PHARMACEUTICAL & BIOTECH COMPANIES
9.3 HEALTHCARE PROVIDERS
9.4 ACADEMIC INSTITUTES
9.5 RESEARCH CENTERS
9.6 GOVERNMENT ORGANIZATIONS
9.7 OTHER END-USERS 

10 GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET, BY GEOGRAPHY
10.1 OVERVIEW

10.2 NORTH AMERICA

10.2.1 NORTH AMERICA MARKET SNAPSHOT
10.2.2 U.S.
10.2.3 CANADA
10.2.4 MEXICO

10.3 EUROPE

10.3.1 EUROPE MARKET SNAPSHOT
10.3.2 WESTERN EUROPE
10.3.2.1 THE UK
10.3.2.2 GERMANY
10.3.2.3 FRANCE
10.3.2.4 ITALY
10.3.2.5 SPAIN
10.3.2.6 REST OF WESTERN EUROPE
10.3.3 EASTERN EUROPE
10.3.3.1 POLAND
10.3.3.2 RUSSIA
10.3.3.3 REST OF EASTERN EUROPE

10.4 ASIA PACIFIC

10.4.1 ASIA PACIFIC MARKET SNAPSHOT
10.4.2 CHINA
10.4.3 JAPAN
10.4.4 INDIA
10.4.5 AUSTRALIA & NEW ZEALAND
10.4.6 ASEAN
10.4.7 REST OF ASIA PACIFIC

10.5 MIDDLE EAST & AFRICA

10.5.1 MIDDLE EAST & AFRICA MARKET SNAPSHOT
10.5.2 UAE
10.5.3 SAUDI ARABIA
10.5.4 SOUTH AFRICA
10.5.5 REST OF MEA

10.6 SOUTH AMERICA

10.6.1 SOUTH AMERICA MARKET SNAPSHOT
10.6.2 BRAZIL
10.6.3 ARGENTINA
10.6.4 REST OF SOUTH AMERICA

11 GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 COMPANY MARKET RANKING
11.3 KEY DEVELOPMENT STRATEGIES

12 COMPANY PROFILES

12.1 BENEVOLENTAI
12.1.1 OVERVIEW
12.1.2 FINANCIAL PERFORMANCE
12.1.3 PRODUCT OUTLOOK
12.1.4 KEY DEVELOPMENTS

12.2 CAMBRIDGE CANCER GENOMICS
12.2.1 OVERVIEW
12.2.2 FINANCIAL PERFORMANCE
12.2.3 PRODUCT OUTLOOK
12.2.4 KEY DEVELOPMENTS

12.3 DATA4CURE INCORPORATED
12.3.1 OVERVIEW
12.3.2 FINANCIAL PERFORMANCE
12.3.3 PRODUCT OUTLOOK
12.3.4 KEY DEVELOPMENTS

12.4 DEEP GENOMICS
12.4.1 OVERVIEW
12.4.2 FINANCIAL PERFORMANCE
12.4.3 PRODUCT OUTLOOK
12.4.4 KEY DEVELOPMENTS

12.5 FABRIC GENOMICS INCORPORATED
12.5.1 OVERVIEW
12.5.2 FINANCIAL PERFORMANCE
12.5.3 PRODUCT OUTLOOK
12.5.4 KEY DEVELOPMENTS

12.6 FREENOME HOLDINGS, INCORPORATED
12.6.1 OVERVIEW
12.6.2 FINANCIAL PERFORMANCE
12.6.3 PRODUCT OUTLOOK
12.6.4 KEY DEVELOPMENTS

12.7 GENOOX LIMITED
12.7.1 OVERVIEW
12.7.2 FINANCIAL PERFORMANCE
12.7.3 PRODUCT OUTLOOK
12.7.4 KEY DEVELOPMENTS

12.8. IBM
12.8.1 OVERVIEW
12.8.2 FINANCIAL PERFORMANCE
12.8.3 PRODUCT OUTLOOK
12.8.4 KEY DEVELOPMENTS

12.9 LIFEBIT MICROSOFT
12.9.1 OVERVIEW
12.9.2 FINANCIAL PERFORMANCE
12.9.3 PRODUCT OUTLOOK
12.9.4 KEY DEVELOPMENTS

12.10 MOLECULARMATCH INCORPORATED
12.10.1 OVERVIEW
12.10.2 FINANCIAL PERFORMANCE
12.10.3 PRODUCT OUTLOOK
12.10.4 KEY DEVELOPMENTS

12.11 NVIDIA CORPORATION
12.11.1 OVERVIEW
12.11.2 FINANCIAL PERFORMANCE
12.11.3 PRODUCT OUTLOOK
12.11.4 KEY DEVELOPMENTS

12.12 PRECISIONLIFE LIMITED
12.12.1 OVERVIEW
12.12.2 FINANCIAL PERFORMANCE
12.12.3 PRODUCT OUTLOOK
12.12.4 KEY DEVELOPMENTS

12.13 SOPHIA GENETICS
12.13.1 OVERVIEW
12.13.2 FINANCIAL PERFORMANCE
12.13.3 PRODUCT OUTLOOK
12.13.4 KEY DEVELOPMENTS

12.14 VERGE GENOMICS
12.14.1 OVERVIEW
12.14.2 FINANCIAL PERFORMANCE
12.14.3 PRODUCT OUTLOOK
12.14.4 KEY DEVELOPMENTS